Top Industry Leaders in the Human Insulin Market
Latest Human Insulin Companies Update:
Eli Lilly and Company Received FDA approval for Mounjaro (tirzepatide), a novel dual GIP & GLP-1 receptor agonist for type 2 diabetes, offering potential benefits beyond glycemic control.
Novo Nordisk Launched their Icodec (insulin degludec) pre-filled pen in the US, offering patients a convenient and long-acting insulin option.
Sanofi Partnered with Getz Pharma to improve insulin access in developing countries through affordable pre-mixed insulin products.
Boehringer Ingelheim Collaborated with the United Nations to support diabetes prevention and care programs globally.
Biocon Biopharma Successfully launched Basalog (insulin glargine) biosimilar in India, further increasing competition and lowering insulin costs.
List of Human Insulin Key companies in the market
- Adocia
- Merck & Co.Inc
- Julphar
- Pfizer Inc.
- Bristol-Myers Squibb Company
- GlaxoSmithKline Plc
- Sanofi
- Oramed
- Novo Nordisk India Pvt. Ltd.
- Eli Lilly and Company
- Biocon
- Tonghua Dongbao Pharmaceutical Co., Ltd.